Novel Drug Delivery Systems Market - Global Outlook and Forecast 2021-2027

January 2021 | 109 pages | ID: N05EEE0E09F3EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Novel Drug Delivery Systems in Global, including the following market information:
Global Novel Drug Delivery Systems Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Novel Drug Delivery Systems market was valued at 25330 million in 2020 and is projected to reach US$ 27020 million by 2027, at a CAGR of 1.6% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Novel Drug Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Novel Drug Delivery Systems Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Novel Drug Delivery Systems Market Segment Percentages, By Type, 2020 (%)

• Liposomes
• PEGylated Proteins & Polypeptides
• Polymer Nanoparticle
• Protein–drug Conjugates
• Others

China Novel Drug Delivery Systems Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Novel Drug Delivery Systems Market Segment Percentages, By Application, 2020 (%)

• Hospitals & Clinic
• Cancer Treatment Centers
• Others

Global Novel Drug Delivery Systems Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Novel Drug Delivery Systems Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Novel Drug Delivery Systems Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Novel Drug Delivery Systems Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Amgen
• Teva
• Roche
• UCB(Union Chimique Belge)
• Celgene
• Merck
• Gilead Sciences
• Sanofi
• Pfizer
• Takeda
• Bausch?Lomb
• Samyang Biopharmaceuticals
• Johnson & Johnson
• TOLMAR
• Astellas
• AMAG Pharmaceuticals
• AbbVie
• Dr Reddy
• AstraZeneca
• Aspen
• Acrotech Biopharma
• TWi Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Novel Drug Delivery Systems Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Novel Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NOVEL DRUG DELIVERY SYSTEMS OVERALL MARKET SIZE

2.1 Global Novel Drug Delivery Systems Market Size: 2021 VS 2027
2.2 Global Novel Drug Delivery Systems Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Novel Drug Delivery Systems Players in Global Market
3.2 Top Global Novel Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Novel Drug Delivery Systems Revenue by Companies
3.4 Top 3 and Top 5 Novel Drug Delivery Systems Companies in Global Market, by Revenue in 2020
3.5 Global Companies Novel Drug Delivery Systems Product Type
3.6 Tier 1, Tier 2 and Tier 3 Novel Drug Delivery Systems Players in Global Market
  3.6.1 List of Global Tier 1 Novel Drug Delivery Systems Companies
  3.6.2 List of Global Tier 2 and Tier 3 Novel Drug Delivery Systems Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Novel Drug Delivery Systems Market Size Markets, 2021 & 2027
  4.1.2 Liposomes
  4.1.3 PEGylated Proteins & Polypeptides
  4.1.4 Polymer Nanoparticle
  4.1.5 Protein–drug Conjugates
  4.1.6 Others
4.2 By Type - Global Novel Drug Delivery Systems Revenue & Forecasts
  4.2.1 By Type - Global Novel Drug Delivery Systems Revenue, 2016-2021
  4.2.2 By Type - Global Novel Drug Delivery Systems Revenue, 2022-2027
  4.2.3 By Type - Global Novel Drug Delivery Systems Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Novel Drug Delivery Systems Market Size, 2021 & 2027
  5.1.2 Hospitals & Clinic
  5.1.3 Cancer Treatment Centers
  5.1.4 Others
5.2 By Application - Global Novel Drug Delivery Systems Revenue & Forecasts
  5.2.1 By Application - Global Novel Drug Delivery Systems Revenue, 2016-2021
  5.2.2 By Application - Global Novel Drug Delivery Systems Revenue, 2022-2027
  5.2.3 By Application - Global Novel Drug Delivery Systems Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Novel Drug Delivery Systems Market Size, 2021 & 2027
6.2 By Region - Global Novel Drug Delivery Systems Revenue & Forecasts
  6.2.1 By Region - Global Novel Drug Delivery Systems Revenue, 2016-2021
  6.2.2 By Region - Global Novel Drug Delivery Systems Revenue, 2022-2027
  6.2.3 By Region - Global Novel Drug Delivery Systems Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Novel Drug Delivery Systems Revenue, 2016-2027
  6.3.2 US Novel Drug Delivery Systems Market Size, 2016-2027
  6.3.3 Canada Novel Drug Delivery Systems Market Size, 2016-2027
  6.3.4 Mexico Novel Drug Delivery Systems Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Novel Drug Delivery Systems Revenue, 2016-2027
  6.4.2 Germany Novel Drug Delivery Systems Market Size, 2016-2027
  6.4.3 France Novel Drug Delivery Systems Market Size, 2016-2027
  6.4.4 U.K. Novel Drug Delivery Systems Market Size, 2016-2027
  6.4.5 Italy Novel Drug Delivery Systems Market Size, 2016-2027
  6.4.6 Russia Novel Drug Delivery Systems Market Size, 2016-2027
  6.4.7 Nordic Countries Novel Drug Delivery Systems Market Size, 2016-2027
  6.4.8 Benelux Novel Drug Delivery Systems Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Novel Drug Delivery Systems Revenue, 2016-2027
  6.5.2 China Novel Drug Delivery Systems Market Size, 2016-2027
  6.5.3 Japan Novel Drug Delivery Systems Market Size, 2016-2027
  6.5.4 South Korea Novel Drug Delivery Systems Market Size, 2016-2027
  6.5.5 Southeast Asia Novel Drug Delivery Systems Market Size, 2016-2027
  6.5.6 India Novel Drug Delivery Systems Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Novel Drug Delivery Systems Revenue, 2016-2027
  6.6.2 Brazil Novel Drug Delivery Systems Market Size, 2016-2027
  6.6.3 Argentina Novel Drug Delivery Systems Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Novel Drug Delivery Systems Revenue, 2016-2027
  6.7.2 Turkey Novel Drug Delivery Systems Market Size, 2016-2027
  6.7.3 Israel Novel Drug Delivery Systems Market Size, 2016-2027
  6.7.4 Saudi Arabia Novel Drug Delivery Systems Market Size, 2016-2027
  6.7.5 UAE Novel Drug Delivery Systems Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Amgen
  7.1.1 Amgen Corporate Summary
  7.1.2 Amgen Business Overview
  7.1.3 Amgen Novel Drug Delivery Systems Major Product Offerings
  7.1.4 Amgen Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.1.5 Amgen Key News
7.2 Teva
  7.2.1 Teva Corporate Summary
  7.2.2 Teva Business Overview
  7.2.3 Teva Novel Drug Delivery Systems Major Product Offerings
  7.2.4 Teva Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.2.5 Teva Key News
7.3 Roche
  7.3.1 Roche Corporate Summary
  7.3.2 Roche Business Overview
  7.3.3 Roche Novel Drug Delivery Systems Major Product Offerings
  7.3.4 Roche Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.3.5 Roche Key News
7.4 UCB(Union Chimique Belge)
  7.4.1 UCB(Union Chimique Belge) Corporate Summary
  7.4.2 UCB(Union Chimique Belge) Business Overview
  7.4.3 UCB(Union Chimique Belge) Novel Drug Delivery Systems Major Product Offerings
  7.4.4 UCB(Union Chimique Belge) Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.4.5 UCB(Union Chimique Belge) Key News
7.5 Celgene
  7.5.1 Celgene Corporate Summary
  7.5.2 Celgene Business Overview
  7.5.3 Celgene Novel Drug Delivery Systems Major Product Offerings
  7.5.4 Celgene Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.5.5 Celgene Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Novel Drug Delivery Systems Major Product Offerings
  7.6.4 Merck Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.6.5 Merck Key News
7.7 Gilead Sciences
  7.7.1 Gilead Sciences Corporate Summary
  7.7.2 Gilead Sciences Business Overview
  7.7.3 Gilead Sciences Novel Drug Delivery Systems Major Product Offerings
  7.4.4 Gilead Sciences Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.7.5 Gilead Sciences Key News
7.8 Sanofi
  7.8.1 Sanofi Corporate Summary
  7.8.2 Sanofi Business Overview
  7.8.3 Sanofi Novel Drug Delivery Systems Major Product Offerings
  7.8.4 Sanofi Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.8.5 Sanofi Key News
7.9 Pfizer
  7.9.1 Pfizer Corporate Summary
  7.9.2 Pfizer Business Overview
  7.9.3 Pfizer Novel Drug Delivery Systems Major Product Offerings
  7.9.4 Pfizer Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.9.5 Pfizer Key News
7.10 Takeda
  7.10.1 Takeda Corporate Summary
  7.10.2 Takeda Business Overview
  7.10.3 Takeda Novel Drug Delivery Systems Major Product Offerings
  7.10.4 Takeda Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.10.5 Takeda Key News
7.11 Bausch?Lomb
  7.11.1 Bausch?Lomb Corporate Summary
  7.11.2 Bausch?Lomb Business Overview
  7.11.3 Bausch?Lomb Novel Drug Delivery Systems Major Product Offerings
  7.11.4 Bausch?Lomb Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.11.5 Bausch?Lomb Key News
7.12 Samyang Biopharmaceuticals
  7.12.1 Samyang Biopharmaceuticals Corporate Summary
  7.12.2 Samyang Biopharmaceuticals Business Overview
  7.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Major Product Offerings
  7.12.4 Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.12.5 Samyang Biopharmaceuticals Key News
7.13 Johnson & Johnson
  7.13.1 Johnson & Johnson Corporate Summary
  7.13.2 Johnson & Johnson Business Overview
  7.13.3 Johnson & Johnson Novel Drug Delivery Systems Major Product Offerings
  7.13.4 Johnson & Johnson Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.13.5 Johnson & Johnson Key News
7.14 TOLMAR
  7.14.1 TOLMAR Corporate Summary
  7.14.2 TOLMAR Business Overview
  7.14.3 TOLMAR Novel Drug Delivery Systems Major Product Offerings
  7.14.4 TOLMAR Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.14.5 TOLMAR Key News
7.15 Astellas
  7.15.1 Astellas Corporate Summary
  7.15.2 Astellas Business Overview
  7.15.3 Astellas Novel Drug Delivery Systems Major Product Offerings
  7.15.4 Astellas Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.15.5 Astellas Key News
7.16 AMAG Pharmaceuticals
  7.16.1 AMAG Pharmaceuticals Corporate Summary
  7.16.2 AMAG Pharmaceuticals Business Overview
  7.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Major Product Offerings
  7.16.4 AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.16.5 AMAG Pharmaceuticals Key News
7.17 AbbVie
  7.17.1 AbbVie Corporate Summary
  7.17.2 AbbVie Business Overview
  7.17.3 AbbVie Novel Drug Delivery Systems Major Product Offerings
  7.17.4 AbbVie Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.17.5 AbbVie Key News
7.18 Dr Reddy
  7.18.1 Dr Reddy Corporate Summary
  7.18.2 Dr Reddy Business Overview
  7.18.3 Dr Reddy Novel Drug Delivery Systems Major Product Offerings
  7.18.4 Dr Reddy Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.18.5 Dr Reddy Key News
7.19 AstraZeneca
  7.19.1 AstraZeneca Corporate Summary
  7.19.2 AstraZeneca Business Overview
  7.19.3 AstraZeneca Novel Drug Delivery Systems Major Product Offerings
  7.19.4 AstraZeneca Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.19.5 AstraZeneca Key News
7.20 Aspen
  7.20.1 Aspen Corporate Summary
  7.20.2 Aspen Business Overview
  7.20.3 Aspen Novel Drug Delivery Systems Major Product Offerings
  7.20.4 Aspen Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.20.5 Aspen Key News
7.21 Acrotech Biopharma
  7.21.1 Acrotech Biopharma Corporate Summary
  7.21.2 Acrotech Biopharma Business Overview
  7.21.3 Acrotech Biopharma Novel Drug Delivery Systems Major Product Offerings
  7.21.4 Acrotech Biopharma Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.21.5 Acrotech Biopharma Key News
7.22 TWi Pharmaceuticals
  7.22.1 TWi Pharmaceuticals Corporate Summary
  7.22.2 TWi Pharmaceuticals Business Overview
  7.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Major Product Offerings
  7.22.4 TWi Pharmaceuticals Novel Drug Delivery Systems Revenue in Global (2016-2021)
  7.22.5 TWi Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Novel Drug Delivery Systems Market Opportunities & Trends in Global Market
Table 2. Novel Drug Delivery Systems Market Drivers in Global Market
Table 3. Novel Drug Delivery Systems Market Restraints in Global Market
Table 4. Key Players of Novel Drug Delivery Systems in Global Market
Table 5. Top Novel Drug Delivery Systems Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Novel Drug Delivery Systems Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Novel Drug Delivery Systems Revenue Share by Companies, 2016-2021
Table 8. Global Companies Novel Drug Delivery Systems Product Type
Table 9. List of Global Tier 1 Novel Drug Delivery Systems Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Novel Drug Delivery Systems Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Novel Drug Delivery Systems Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Novel Drug Delivery Systems Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Novel Drug Delivery Systems Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Novel Drug Delivery Systems Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Novel Drug Delivery Systems Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Novel Drug Delivery Systems Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Novel Drug Delivery Systems Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Novel Drug Delivery Systems Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Novel Drug Delivery Systems Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Novel Drug Delivery Systems Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Novel Drug Delivery Systems Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Novel Drug Delivery Systems Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Novel Drug Delivery Systems Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Novel Drug Delivery Systems Revenue, (US$, Mn), 2022-2027
Table 30. Amgen Corporate Summary
Table 31. Amgen Novel Drug Delivery Systems Product Offerings
Table 32. Amgen Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 33. Teva Corporate Summary
Table 34. Teva Novel Drug Delivery Systems Product Offerings
Table 35. Teva Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 36. Roche Corporate Summary
Table 37. Roche Novel Drug Delivery Systems Product Offerings
Table 38. Roche Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 39. UCB(Union Chimique Belge) Corporate Summary
Table 40. UCB(Union Chimique Belge) Novel Drug Delivery Systems Product Offerings
Table 41. UCB(Union Chimique Belge) Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 42. Celgene Corporate Summary
Table 43. Celgene Novel Drug Delivery Systems Product Offerings
Table 44. Celgene Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 45. Merck Corporate Summary
Table 46. Merck Novel Drug Delivery Systems Product Offerings
Table 47. Merck Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 48. Gilead Sciences Corporate Summary
Table 49. Gilead Sciences Novel Drug Delivery Systems Product Offerings
Table 50. Gilead Sciences Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Novel Drug Delivery Systems Product Offerings
Table 53. Sanofi Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Novel Drug Delivery Systems Product Offerings
Table 56. Pfizer Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 57. Takeda Corporate Summary
Table 58. Takeda Novel Drug Delivery Systems Product Offerings
Table 59. Takeda Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 60. Bausch?Lomb Corporate Summary
Table 61. Bausch?Lomb Novel Drug Delivery Systems Product Offerings
Table 62. Bausch?Lomb Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 63. Samyang Biopharmaceuticals Corporate Summary
Table 64. Samyang Biopharmaceuticals Novel Drug Delivery Systems Product Offerings
Table 65. Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 66. Johnson & Johnson Corporate Summary
Table 67. Johnson & Johnson Novel Drug Delivery Systems Product Offerings
Table 68. Johnson & Johnson Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 69. TOLMAR Corporate Summary
Table 70. TOLMAR Novel Drug Delivery Systems Product Offerings
Table 71. TOLMAR Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 72. Astellas Corporate Summary
Table 73. Astellas Novel Drug Delivery Systems Product Offerings
Table 74. Astellas Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 75. AMAG Pharmaceuticals Corporate Summary
Table 76. AMAG Pharmaceuticals Novel Drug Delivery Systems Product Offerings
Table 77. AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 78. AbbVie Corporate Summary
Table 79. AbbVie Novel Drug Delivery Systems Product Offerings
Table 80. AbbVie Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 81. Dr Reddy Corporate Summary
Table 82. Dr Reddy Novel Drug Delivery Systems Product Offerings
Table 83. Dr Reddy Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 84. AstraZeneca Corporate Summary
Table 85. AstraZeneca Novel Drug Delivery Systems Product Offerings
Table 86. AstraZeneca Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 87. Aspen Corporate Summary
Table 88. Aspen Novel Drug Delivery Systems Product Offerings
Table 89. Aspen Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 90. Acrotech Biopharma Corporate Summary
Table 91. Acrotech Biopharma Novel Drug Delivery Systems Product Offerings
Table 92. Acrotech Biopharma Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)
Table 93. TWi Pharmaceuticals Corporate Summary
Table 94. TWi Pharmaceuticals Novel Drug Delivery Systems Product Offerings
Table 95. TWi Pharmaceuticals Novel Drug Delivery Systems Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Novel Drug Delivery Systems Segment by Type
Figure 2. Novel Drug Delivery Systems Segment by Application
Figure 3. Global Novel Drug Delivery Systems Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Novel Drug Delivery Systems Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Novel Drug Delivery Systems Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Novel Drug Delivery Systems Revenue in 2020
Figure 8. By Type - Global Novel Drug Delivery Systems Revenue Market Share, 2016-2027
Figure 9. By Application - Global Novel Drug Delivery Systems Revenue Market Share, 2016-2027
Figure 10. By Region - Global Novel Drug Delivery Systems Revenue Market Share, 2016-2027
Figure 11. By Country - North America Novel Drug Delivery Systems Revenue Market Share, 2016-2027
Figure 12. US Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Novel Drug Delivery Systems Revenue Market Share, 2016-2027
Figure 16. Germany Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 17. France Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Novel Drug Delivery Systems Revenue Market Share, 2016-2027
Figure 24. China Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 28. India Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Novel Drug Delivery Systems Revenue Market Share, 2016-2027
Figure 30. Brazil Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Novel Drug Delivery Systems Revenue Market Share, 2016-2027
Figure 33. Turkey Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Novel Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 37. Amgen Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Teva Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Roche Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. UCB(Union Chimique Belge) Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Celgene Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Merck Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Gilead Sciences Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Sanofi Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Pfizer Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Takeda Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Bausch?Lomb Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Johnson & Johnson Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. TOLMAR Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Astellas Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. AbbVie Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Dr Reddy Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. AstraZeneca Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Aspen Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. Acrotech Biopharma Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2016-2021)